Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL231313 | 0.86 | ALDH1A1 (0.42) | ALDH1A1THRBTSHRPOLBAPEX1 | |
| SCHEMBL231818 | 0.84 | THRB (0.42) | ALDH1A1THRBTSHRPOLBAPEX1 | |
| SCHEMBL237865 | 0.84 | TSHR (0.49) | ALDH1A1THRBTSHRPOLBAPEX1 | |
| SCHEMBL230556 | 0.82 | TSHR (0.47) | ALDH1A1THRBTSHRPOLBAPEX1 | |
| SCHEMBL5699018 | 0.81 | TSHR (0.54) | ALDH1A1THRBTSHRPOLBAPEX1 | |
| SCHEMBL143881 | 0.80 | THRB (0.48) | ALDH1A1THRBTSHRPOLBAPEX1 | |
| SCHEMBL145163 | 0.80 | TSHR (0.45) | ALDH1A1THRBTSHRPOLBAPEX1 | |
| SCHEMBL666441 | 0.79 | TSHR (0.44) | ALDH1A1THRBTSHR | |
| SCHEMBL9757143 | 0.78 | TSHR (0.50) | ALDH1A1THRBTSHRPOLBAPEX1 | |
| SCHEMBL27357 | 0.77 | THRB (0.63) | ALDH1A1THRBTSHRPOLBAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2941460-B1 | ONE -COMPONENT, CURABLE COATING COMPOSITION, PROCESSES FOR MAKING AND USING THEM, AND COATINGS AND ARTICLES PREPARED WITH THEM | BASF COATINGS GMBH (DE) | 2017-11-22 | — | — | EP | disclosed |
| US-9683125-B2 | One-component, curable coating compositions, processes for making and using them, and coatings and articles prepared with them | BASF COATINGS GMBH (DE) | 2017-06-20 | — | — | US | disclosed |
| US-20150337159-A1 | One-Component, Curable Coating Compositions, Processes For Making And Using Them, And Coatings And Articles Prepared With Them | BASF COATINGS GMBH (DE) | 2015-11-26 | — | — | US | disclosed |
| EP-2941460-A1 | ONE -COMPONENT, CURABLE COATING COMPOSITION, PROCESSES FOR MAKING AND USING THEM, AND COATINGS AND ARTICLES PREPARED WITH THEM | BASF Coatings GmbH (DE) | 2015-11-11 | — | — | EP | disclosed |
| US-8865851-B2 | Moisture-curing coating compositions comprising aprotic solvents and binders having alkoxysilane groups and method of forming a multicoat finish therewith | BASF COATINGS GMBH (DE) | 2014-10-21 | — | — | US | disclosed |
| WO-2014106552-A1 | ONE -COMPONENT, CURABLE COATING COMPOSITION, PROCESSES FOR MAKING AND USING THEM, AND COATINGS AND ARTICLES PREPARED WITH THEM | BASF COATINGS GMBH (DE) | 2014-07-10 | — | — | WO | disclosed |
| EP-2414466-B1 | MOISTURE-CURING COATING COMPOSITIONS BASED ON APROTIC SOLVENTS, COMPRISING BINDERS HAVING ALKOXYSILANE GROUPS, AND THE USE THEREOF | BASF COATINGS GMBH (DE) | 2013-10-16 | — | — | EP | disclosed |
| US-8247590-B2 | Method for preventing polymerization of unsaturated organosilicon compounds | WACKER CHEMIE AG (DE) | 2012-08-21 | — | — | US | disclosed |
| EP-2334690-B1 | METHOD FOR PRODUCING (METH)ACRYLOSILANES | WACKER CHEMIE AG (DE) | 2012-07-25 | — | — | EP | disclosed |
| EP-2300486-B1 | METHOD FOR PREVENTING POLYMERIZATION OF UNSATURATED ORGANOSILICON COMPOUNDS | WACKER CHEMIE AG (DE) | 2012-03-28 | — | — | EP | disclosed |
| WO-2010112106-A1 | MOISTURE-CURING COATING COMPOSITIONS BASED ON APROTIC SOLVENTS, COMPRISING BINDERS HAVING ALKOXYSILANE GROUPS, AND THE USE THEREOF | BASF COATINGS AG (DE) | 2010-10-07 | — | — | WO | disclosed |
| US-7619108-B2 | Process for preparing unsaturated organosilicon compounds | WACKER CHEMIE AG (DE) | 2009-11-17 | — | — | US | disclosed |
| EP-1954701-B1 | PROCESS FOR PREPARING UNSATURATED ORGANOSILICON COMPOUNDS | WACKER CHEMIE AG (DE) | 2009-03-18 | — | — | EP | disclosed |
| US-20080293958-A1 | Process for Preparing Unsaturated Organosilicon Compounds | WACKER CHEMIE AG (DE) | 2008-11-27 | — | — | US | disclosed |
| US-6841694-B2 | Process for stabilizing unsaturated organosilicon compounds | WACKER-CHEMIE GMBH (DE) | 2005-01-11 | — | — | US | disclosed |
| US-6815554-B2 | REACTING A HALOALKYLSILANE WITH A SALT OF AN UNSATURATED CARBOXYLIC ACID IN THE PRESENCE OF A PHASE TRANSFER CATALYST; BONDING AGENTS | WACKER-CHEMIE GMBH (DE) | 2004-11-09 | — | — | US | disclosed |
| EP-1469002-A1 | Method for stabilizing unsaturated organo-silicon compounds | Wacker-Chemie GmbH (DE) | 2004-10-20 | — | — | EP | disclosed |
| US-20040171859-A1 | Process for stabilizing unsaturated organosilicon compounds | WACKER-CHEMIE GMBH (DE) | 2004-09-02 | — | — | US | disclosed |
| US-20020151736-A1 | PROCESS FOR PREPARING UNSATURATED ORGANOSILICON COMPOUNDS | WACKER-CHEMIE GMBH (DE) | 2002-10-17 | — | — | US | disclosed |
| EP-1249454-A1 | Preparation of unsaturated organo-silicon compounds | Wacker-Chemie GmbH (DE) | 2002-10-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171859-A1 | Process for stabilizing unsaturated organosilicon compounds | ELOVL1, ELOVL6, DEGS1 | ALDH1A1 402/4885THRB 4533/4885TSHR 4650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.